Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125908201 | 12590820 | 1 | I | 2015 | 20160711 | 20160726 | 20160726 | EXP | US-CIPLA LTD.-2016US09708 | CIPLA | 0.00 | Y | 0.00000 | 20160726 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125908201 | 12590820 | 1 | PS | GABAPENTIN. | GABAPENTIN | 1 | Unknown | UNK | 0 | CAPSULE | |||||||||
| 125908201 | 12590820 | 2 | SS | GABAPENTIN. | GABAPENTIN | 1 | Oral | 300 MG, TID | 0 | 300 | MG | CAPSULE | |||||||
| 125908201 | 12590820 | 3 | SS | GABAPENTIN. | GABAPENTIN | 1 | Oral | EXTRA TWO CAPSULES FOR TWO NIGHTS | 0 | CAPSULE | |||||||||
| 125908201 | 12590820 | 4 | SS | GABAPENTIN. | GABAPENTIN | 1 | Oral | 300 MG, TID | 0 | 300 | MG | CAPSULE | |||||||
| 125908201 | 12590820 | 5 | SS | OPDIVO | NIVOLUMAB | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 125908201 | 12590820 | 6 | C | Fish oil | FISH OIL | 1 | Oral | 1200 MG, QD | U | U | 0 | 1200 | MG | CAPSULE | |||||
| 125908201 | 12590820 | 7 | C | Magnesium | MAGNESIUM | 1 | Oral | 250 MG, QD | U | U | 0 | 250 | MG | TABLET | |||||
| 125908201 | 12590820 | 8 | C | Calcium | CALCIUM | 1 | Oral | 600 MG, QD | U | U | 0 | 600 | MG | TABLET | |||||
| 125908201 | 12590820 | 9 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | Oral | 2500 MCG, QD | U | U | 0 | 2500 | UG | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125908201 | 12590820 | 1 | Neuropathy peripheral |
| 125908201 | 12590820 | 2 | Restless legs syndrome |
| 125908201 | 12590820 | 5 | Lung neoplasm malignant |
| 125908201 | 12590820 | 6 | Hypercholesterolaemia |
| 125908201 | 12590820 | 7 | Muscle spasms |
| 125908201 | 12590820 | 8 | Mineral supplementation |
| 125908201 | 12590820 | 9 | Supplementation therapy |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125908201 | 12590820 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125908201 | 12590820 | Abnormal behaviour | |
| 125908201 | 12590820 | Aortic bypass | |
| 125908201 | 12590820 | Condition aggravated | |
| 125908201 | 12590820 | Drug ineffective | |
| 125908201 | 12590820 | Insomnia | |
| 125908201 | 12590820 | Lung neoplasm malignant | |
| 125908201 | 12590820 | Neuropathy peripheral | |
| 125908201 | 12590820 | Post procedural complication |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125908201 | 12590820 | 1 | 2001 | 2001 | 0 | |
| 125908201 | 12590820 | 2 | 2005 | 0 | ||
| 125908201 | 12590820 | 3 | 201605 | 201605 | 0 | |
| 125908201 | 12590820 | 4 | 2016 | 0 |